bpc-157 human clinical trials athletic performance and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157: What the Science Says

It does not make 2.5 mg a dose-isolated long-term maintenance trial or equal to the 5 mg obesity-trial floor

It was used clinically in over 35 countries before the FDAs Category 2 restriction

BPC-157 is the short name for Body Protection Compound 157

PubMed laboratory research record [PMID: 9216477] PubMed record related to this compound for laboratory literature review

Browse user-created protocols Real protocols from the community that include Glow Blend Glow Blend Research References It is a preclinical compound Glow Blend Glow Blend is a preclinical compound Dose range 250-500mcg daily shows wound healing and anti-inflammatory properties n.d

Researchers studying the individual compounds separately may prefer the standalone BPC-157 10mg and TB-500 10mg preparations